Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Zogenix, Inc.    ZGNX

ZOGENIX, INC. (ZGNX)
Mes dernières consult.
Most popular
Report
Delayed Quote. Delayed  - 11/17 10:00:00 pm
36.55 USD   -0.54%
11/14 Zogenix to Present at Stifel 2017 Healthcare Conference
11/07 ZOGENIX : reports 3Q loss
11/07 Zogenix Provides Corporate Update and Reports Third Quarter 2017 ..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/13/2017 11/14/2017 11/15/2017 11/16/2017 11/17/2017 Date
38(c) 37.2(c) 36.95(c) 36.75(c) 36.55(c) Last
826 086 708 046 758 004 390 681 411 217 Volume
-4.64% -2.11% -0.67% -0.54% -0.54% Change
More quotes
Financials ($)
Sales 2017 9,81 M
EBIT 2017 -100 M
Net income 2017 -102 M
Finance 2017 263 M
Yield 2017 -
Sales 2018 -
EBIT 2018 -102 M
Net income 2018 -104 M
Finance 2018 13,3 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 90,7x
EV / Sales2018 0
Capitalization 1 153 M
More Financials
Company
Zogenix, Inc. is a pharmaceutical company, which engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders.It develops two products candidate: ZX008 and Relday.The company was founded by Stephen... 
More about the company
Surperformance© ratings of Zogenix, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on ZOGENIX, INC.
11/14 Zogenix to Present at Stifel 2017 Healthcare Conference
11/07 ZOGENIX : Management's Discussion and Analysis of Financial Condition and Result..
11/07 ZOGENIX : reports 3Q loss
11/07 ZOGENIX, INC. : Results of Operations and Financial Condition, Financial Stateme..
11/07 Zogenix Provides Corporate Update and Reports Third Quarter 2017 Financial Re..
11/07 ZOGENIX, INC. : to Host Earnings Call
11/02 ZOGENIX : to Release Third Quarter 2017 Financial Results and Host Conference Ca..
10/31 Zogenix to Release Third Quarter 2017 Financial Results and Host Conference C..
10/23 ZOGENIX INC. : - High Seizure Frequency in Children with Dravet Syndrome Negativ..
10/19 ZOGENIX : High Seizure Frequency in Children with Dravet Syndrome Negatively Imp..
More news
Sector news : Bio Medical Devices
11/16 Recovery rally for European stocks leaves oil sector behind
11/13 Poor earnings updates keep European shares at seven-week low
11/13DJNOVARTIS : Vision Drug Shows Positive Results in Phase 3 Trials
11/03 Prosecutors search Metro offices in insider trading probe
11/01DJAs Experimental Treatments Grow, Families Face Tough Choices
More sector news : Bio Medical Devices
News from SeekingAlpha
11/16 Zogenix (ZGNX) Presents At Stifel 2017 Healthcare Conference - Slideshow
11/12 Market Wisdom From A Bioscience Expert - An Integrated BioSci Interview
11/07 Zogenix's (ZGNX) CEO Stephen Farr on Q3 2017 Results - Earnings Call Transcri..
11/07 Zogenix misses by $0.75
11/06 Notable earnings after Tuesday?s close
Chart ZOGENIX, INC.
Duration : Period :
Zogenix, Inc. Technical Analysis Chart | ZGNX | US98978L2043 | 4-Traders
Technical analysis trends ZOGENIX, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Average target price 49,0 $
Spread / Average Target 34%
EPS Revisions
Managers
NameTitle
Stephen J. Farr President, Chief Executive Officer & Director
Cam L. Garner Chairman
Michael P. Smith CFO, Secretary, Treasurer & Executive VP
Bradley S. Galer Chief Medical Officer & Executive Vice President
Roger L. Hawley Director
Sector and Competitors
1st jan.Capitalization (M$)
ZOGENIX, INC.200.82%1 153
GILEAD SCIENCES1.16%94 601
REGENERON PHARMACEUTICALS6.67%42 072
VERTEX PHARMACEUTICALS100.10%37 280
CELLTRION, INC.--.--%24 558
INCYTE CORPORATION5.19%22 258